Aug 2026· Journal of Hypertension· Vol 44, pp. 1822 - 1829· 0 citations· 38 references
Medicine
TL;DR
The prevalence of hypertension-associated cardiac damage was higher in WCHT and in MHT compared to SNT and WCHT should be considered when assessing cardiovascular risk, and BP should be measured both in the office and at home when diagnosing and monitoring hypertension.
Abstract
Background: The aim of this study was to characterize hypertension-associated cardiac damage in the blood pressure (BP) phenotypes sustained normotension (SNT), white coat hypertension (WCHT), masked hypertension (MHT) and sustained hypertension (SHT). Methods: In a population-based study, 4115 individuals were examined with office and home BP measurement, computed tomography, coronary computed tomography angiography and echocardiography. The odds ratios of hypertension-associated cardiac damage in the BP phenotypes were analysed with SNT and SHT as references, respectively, for coronary artery calcium score (CACS) at least 100 and at least 300, Segment Involvement Score (SIS) at least 4, any significant (>50%) coronary stenosis, left ventricular ejection fraction (LVEF) less than 50%, E/e΄ ratio (E/e΄) at least 14, and global longitudinal strain (GLS) greater than −17 (men) or greater than −18 (women). Results: The odds of having hypertension-associated cardiac damage were significantly higher for WCHT than for SNT [LVEF < 50%: OR 1.83 (1.17–2.86), CACS ≥ 100: OR 1.58 (1.19–2.11)], and for SHT than for SNT [LVEF < 50%: OR 2.34 (1.53–3.57), CACS ≥ 100: OR 1.52 (1.14–2.02)]. The odds of having hypertension-associated cardiac damage were also significantly higher for MHT than for SNT (LVEF < 50%: OR 2.68 (1.41–5.10), CACS ≥ 100: OR 2.15 (1.37–3.38) and CACS ≥ 300: OR 2.34 (2.21–4.52)]. Conclusion: The prevalence of hypertension-associated cardiac damage was higher in WCHT and in MHT compared to SNT. WCHT and MHT should therefore be considered when assessing cardiovascular risk, and BP should be measured both in the office and at home when diagnosing and monitoring hypertension.
Background: Electrocardiographic (ECG) markers of atrial cardiopathy (AC) are associated with stroke mortality, but whether this association is modified by blood pressure (BP) is unknown. Methods: We analyzed 7,191 adults free of cardiovascular disease from the Third National Health and Nutrition Examination Survey who...
A. Mohsen, M. Elnewishy, P. Cheon et al.· medRxiv· 0 citations
Background and Objectives: Lipoprotein(a) [Lp(a)] is an established cardiovascular risk factor associated with atherosclerosis, vascular inflammation, and endothelial dysfunction. However, data regarding its relationship with hypertension-mediated organ damage and circadian blood pressure abnormalities remain limited....
T. Kunak, Ayşegül Ülgen Kunak, I. Basarici· Medicina· 0 citations
Elevated MAP was consistently associated with CVD risk in individuals with diabetes, while PP variability offered additional prognostic information, and integrated monitoring of MAP levels and PP variability may help refine vascular risk stratification, pending external validation.
Ling-Jie Kong, Liu Xu, Yinghong Shi et al.· BMC Endocrine Disorders· 0 citations
BACKGROUND
Elevated lipoprotein(a) [Lp(a)] is associated with atherosclerotic cardiovascular disease across multiple clinical settings, but its relationship with prevalent cardiovascular disease burden among adults with treated hypertension (HTN) remains incompletely characterized.
OBJECTIVE
To evaluate the associati...
N. Renna, M. Arrupe, J. Soumoulou et al.· Journal of Clinical Lipidolo...· 0 citations
Background Prediabetes is common among adults with hypertension, but its contribution to heart failure (HF) risk, particularly in the presence of subclinical myocardial abnormalities, remains uncertain. Objectives The objective of the study was to assess whether prediabetes combined with malignant left ventricular hype...
Arnaud D. Kaze, Stephen P. Juraschek, Jordana B. Cohen et al.· JACC: Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.